Side-by-side financials for CMMB and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CMMB | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #47 |
| Net income (latest FY) | -$8.99M | - |
| SEC filings | 347 | 1,004 |
Full pages: Chemomab Therapeutics Ltd. and AstraZeneca PLC, or browse the full rankings.